David Miklos, MD, PhD of Stanford University Medical Center, discusses ibrutinib in Chronic Graft-versus-Host Disease at the 58th ASH Annual Meeting in San Diego, CA.
Ibrutinib in Chronic GVHD Could Greatly Impact Patient Care
David Miklos, MD, PhD of Stanford University Medical Center, discusses ibrutinib in Chronic Graft-versus-Host Disease at the 58th ASH Annual Meeting in San Diego, CA.